About: http://data.cimple.eu/claim-review/c7815e513576fa53aa41d8d52bab41b5743389b718afe7248986412b     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:ClaimReview, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
http://data.cimple...lizedReviewRating
schema:url
schema:text
  • Articles and social media posts shared thousands of times claim that the US Food and Drug Administration (FDA) did not give full approval to the COVID-19 vaccine from Pfizer-BioNTech. This is false; the agency signed off on the shot for Americans aged 16 and older on August 23, 2021. Also Read: Tennessee Has Not Allowed Forced Relocation To COVID-19 Interment Camps "FDA 'playing bait and switch' with Americans, tricking them into believing shots currently being offered have been granted full approval when they have not," says the headline of an August 25, 2021 article on the LeoHohmann.com website. Screenshot of an online article taken on August 30, 2021 "What was actually given full approval was a separate Pfizer-BioNTech vaccine product which goes by the name Comirnaty," the article says. A Facebook post also claimed that the FDA "'REISSUED' The 'Emergency Use Authorization' (EUA)" instead of approving the vaccine. Similar claims appeared in an article here and on Facebook here and here Comirnaty vs Pfizer Comirnaty is the new name under which Pfizer-BioNTech's FDA-approved COVID-19 vaccine will be marketed. Dr Janet Woodcock, the FDA's Acting Commissioner of Food and Drugs, explained in a media call that Comirnaty and the Pfizer shot are the same. "The FDA-approved vaccine and the EUA-authorized vaccine have the same formulation and can be used interchangeably," she said on August 23. Also Read: Joe Rogan Misinterprets Study To Claim Vaccinated People Create Variants Approval vs EUA While Comirnaty is fully approved in the United States for those 16 and older, "the vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals," an August 23 FDA press release says. While the shots are the same, FDA spokeswoman Veronika Pfaeffle clarified that the EUA will continue to cover the Pfizer-BioNTech-branded vaccines until a sufficient supply with the new Comirnaty name can be manufactured and distributed. AFP Fact Check has debunked other inaccurate claims about vaccines here. (Except for the headline, this story has not been edited by BOOM staff and is published from a syndicated feed.)
schema:mentions
schema:reviewRating
schema:author
schema:datePublished
schema:inLanguage
  • English
schema:itemReviewed
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software